Literature DB >> 29437871

Gut microbiota modulate T cell trafficking into human colorectal cancer.

Eleonora Cremonesi1, Valeria Governa2, Jesus Francisco Glaus Garzon3, Valentina Mele1, Francesca Amicarella1, Manuele Giuseppe Muraro2, Emanuele Trella2, Virginie Galati-Fournier4, Daniel Oertli5, Silvio Raffael Däster5, Raoul A Droeser5, Benjamin Weixler5, Martin Bolli6, Raffaele Rosso7, Ulrich Nitsche8, Nina Khanna9, Adrian Egli10, Simone Keck4, Julia Slotta-Huspenina11, Luigi M Terracciano12, Paul Zajac2, Giulio Cesare Spagnoli2, Serenella Eppenberger-Castori12, Klaus-Peter Janssen8, Lubor Borsig3, Giandomenica Iezzi1.   

Abstract

OBJECTIVE: Tumour-infiltrating lymphocytes (TILs) favour survival in human colorectal cancer (CRC). Chemotactic factors underlying their recruitment remain undefined. We investigated chemokines attracting T cells into human CRCs, their cellular sources and microenvironmental triggers.
DESIGN: Expression of genes encoding immune cell markers, chemokines and bacterial 16S ribosomal RNA (16SrRNA) was assessed by quantitative reverse transcription-PCR in fresh CRC samples and corresponding tumour-free tissues. Chemokine receptor expression on TILs was evaluated by flow cytometry on cell suspensions from digested tissues. Chemokine production by CRC cells was evaluated in vitro and in vivo, on generation of intraperitoneal or intracecal tumour xenografts in immune-deficient mice. T cell trafficking was assessed on adoptive transfer of human TILs into tumour-bearing mice. Gut flora composition was analysed by 16SrRNA sequencing.
RESULTS: CRC infiltration by distinct T cell subsets was associated with defined chemokine gene signatures, including CCL5, CXCL9 and CXCL10 for cytotoxic T lymphocytes and T-helper (Th)1 cells; CCL17, CCL22 and CXCL12 for Th1 and regulatory T cells; CXCL13 for follicular Th cells; and CCL20 and CCL17 for interleukin (IL)-17-producing Th cells. These chemokines were expressed by tumour cells on exposure to gut bacteria in vitro and in vivo. Their expression was significantly higher in intracecal than in intraperitoneal xenografts and was dramatically reduced by antibiotic treatment of tumour-bearing mice. In clinical samples, abundance of defined bacteria correlated with high chemokine expression, enhanced T cell infiltration and improved survival.
CONCLUSIONS: Gut microbiota stimulate chemokine production by CRC cells, thus favouring recruitment of beneficial T cells into tumour tissues. © Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted.

Entities:  

Keywords:  T lymphocytes; bacterial translocation; chemokines; colorectal cancer; immune response

Mesh:

Substances:

Year:  2018        PMID: 29437871     DOI: 10.1136/gutjnl-2016-313498

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  56 in total

1.  Clindamycin Administration Increases the Incidence of Collagen-Induced Arthritis in Mice Through the Prolonged Impact of Gut Immunity.

Authors:  Shukai Yang; Huijuan Chen; Bo Wei; Min Xiang; Zibing Hu; Zhiheng Peng; Hao Lin; Jiecong Sun
Journal:  Inflammation       Date:  2018-10       Impact factor: 4.092

2.  Gut Microbiota, the Immune System, and Cytotoxic T Lymphocytes.

Authors:  Carmela Cosola; Maria Teresa Rocchetti; Loreto Gesualdo
Journal:  Methods Mol Biol       Date:  2021

Review 3.  Integration of microbiology, molecular pathology, and epidemiology: a new paradigm to explore the pathogenesis of microbiome-driven neoplasms.

Authors:  Tsuyoshi Hamada; Jonathan A Nowak; Danny A Milner; Mingyang Song; Shuji Ogino
Journal:  J Pathol       Date:  2019-02-20       Impact factor: 7.996

4.  Treating Colorectal Cancer with Immunotherapy: Implications for Single versus Combination Therapy.

Authors:  Sophiya Karki; Shahid Umar; Anup Kasi
Journal:  Curr Colorectal Cancer Rep       Date:  2020-08-20

5.  CCL20 promotes lung adenocarcinoma progression by driving epithelial-mesenchymal transition.

Authors:  Tao Fan; Shuofeng Li; Chu Xiao; He Tian; Yujia Zheng; Yu Liu; Chunxiang Li; Jie He
Journal:  Int J Biol Sci       Date:  2022-06-27       Impact factor: 10.750

6.  Effect of Antimicrobial Prophylaxis on Corynebacterium bovis Infection and the Skin Microbiome of Immunodeficient Mice.

Authors:  Christopher A Manuel; Linda K Johnson; Uma Pugazhenthi; Derek L Fong; Michaelk Fink; Lauren M Habenicht; Jori K Leszczynski; I R Diana; Michael J Schurr; Daniel N Frank
Journal:  Comp Med       Date:  2022-04-04       Impact factor: 1.565

7.  Intratumour microbiome associated with the infiltration of cytotoxic CD8+ T cells and patient survival in cutaneous melanoma.

Authors:  Gongjian Zhu; Haixiang Su; Caroline H Johnson; Sajid A Khan; Harriet Kluger; Lingeng Lu
Journal:  Eur J Cancer       Date:  2021-05-04       Impact factor: 10.002

Review 8.  B Cells and Microbiota in Autoimmunity.

Authors:  María Botía-Sánchez; Marta E Alarcón-Riquelme; Georgina Galicia
Journal:  Int J Mol Sci       Date:  2021-05-03       Impact factor: 5.923

Review 9.  Advances and new frontiers for immunotherapy in colorectal cancer: Setting the stage for neoadjuvant success?

Authors:  Nuttavut Sumransub; Kornpong Vantanasiri; Ajay Prakash; Emil Lou
Journal:  Mol Ther Oncolytics       Date:  2021-05-14       Impact factor: 7.200

Review 10.  Bile Acids, Their Receptors, and the Gut Microbiota.

Authors:  James C Poland; C Robb Flynn
Journal:  Physiology (Bethesda)       Date:  2021-07-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.